PDCD1 and neoplasm: This results in increased collagen synthesis and the formation of a dense extracellular matrix (ECM), which can hinder the effective penetration of macromolecular drugs like anti‐PD‐1/PD‐L1 monoclonal antibodies, limiting their ability to infiltrate tumor tissues.